Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

NCT01706224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 757

Last updated 2014-01-13

No results posted yet for this study

Summary

This study aims to determine the sero-prevalence of anti-pertussis antibodies among healthcare professionals at hospital centres in Spain.

Conditions

  • Pertussis

Interventions

PROCEDURE

Blood sample

Samples will be tested to determine the presence of anti-pertussis antibodies.

OTHER

Data collection

Electronic Case Report Forms (eCRF)

OTHER

Data collection

Questionnaires, active questioning.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01706224 on ClinicalTrials.gov